NO991227D0 - PTX-sensitive G-proteiner, deres fremstilling og bruk - Google Patents

PTX-sensitive G-proteiner, deres fremstilling og bruk

Info

Publication number
NO991227D0
NO991227D0 NO991227A NO991227A NO991227D0 NO 991227 D0 NO991227 D0 NO 991227D0 NO 991227 A NO991227 A NO 991227A NO 991227 A NO991227 A NO 991227A NO 991227 D0 NO991227 D0 NO 991227D0
Authority
NO
Norway
Prior art keywords
ptx
proteins
sensitive
preparation
Prior art date
Application number
NO991227A
Other languages
English (en)
Other versions
NO991227L (no
Inventor
Winfried Siffert
Original Assignee
Winfried Siffert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Winfried Siffert filed Critical Winfried Siffert
Publication of NO991227D0 publication Critical patent/NO991227D0/no
Publication of NO991227L publication Critical patent/NO991227L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
NO991227A 1996-09-13 1999-03-12 PTX-sensitive G-proteiner, deres fremstilling og bruk NO991227L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637518A DE19637518A1 (de) 1996-09-13 1996-09-13 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung
PCT/EP1997/004709 WO1998011212A1 (de) 1996-09-13 1997-08-29 Ptx-sensitive g-proteine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO991227D0 true NO991227D0 (no) 1999-03-12
NO991227L NO991227L (no) 1999-03-12

Family

ID=7805651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991227A NO991227L (no) 1996-09-13 1999-03-12 PTX-sensitive G-proteiner, deres fremstilling og bruk

Country Status (22)

Country Link
US (1) US6251853B1 (no)
EP (1) EP0931145A1 (no)
JP (1) JP2001501811A (no)
KR (1) KR20000036058A (no)
CN (1) CN1230222A (no)
AU (1) AU4619297A (no)
BG (1) BG103238A (no)
BR (1) BR9711475A (no)
CA (1) CA2265467A1 (no)
CZ (1) CZ73499A3 (no)
DE (1) DE19637518A1 (no)
EA (1) EA199900253A1 (no)
EE (1) EE9900092A (no)
HU (1) HUP9904110A3 (no)
IL (1) IL128746A0 (no)
IS (1) IS4987A (no)
NO (1) NO991227L (no)
PL (1) PL332417A1 (no)
SK (1) SK34099A3 (no)
TR (1) TR199900500T2 (no)
WO (1) WO1998011212A1 (no)
ZA (1) ZA978220B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen
WO1999058669A1 (en) * 1998-05-11 1999-11-18 Axys Pharmaceuticals, Inc. Rhoh genes and their uses
WO2000015785A2 (de) * 1998-09-10 2000-03-23 Winfried Siffert GENVERÄNDERUNG IM GEN FÜR DIE Gβ3-UNTEREINHEIT DES HUMANEN G-PROTEINS
FR2803525B1 (fr) * 2000-01-06 2002-05-03 Sod Conseils Rech Applic Inhibiteur de la transduction des signaux des proteines g heterotrimeriques associe a un agent anti-hypertenseur dans le traitement de l'hypertension arterielle
AU2001240585A1 (en) * 2000-02-03 2001-08-14 Snip Biotech Gmbh & Co. Kg Use of a mutation in the gene for the beta3-subunit of human g-protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587561A (en) 1995-07-28 1996-12-24 Budayr; Mahdi Stethoscope shield
DE19619362A1 (de) * 1996-05-14 1997-11-20 Basf Ag Verwendung einer Genveränderung im Gen für humanes G-Protein beta-3-Untereinheit zur Diagnostik von Erkrankungen

Also Published As

Publication number Publication date
BR9711475A (pt) 1999-08-24
AU4619297A (en) 1998-04-02
EA199900253A1 (ru) 1999-10-28
HUP9904110A2 (en) 2000-07-28
TR199900500T2 (xx) 1999-06-21
CN1230222A (zh) 1999-09-29
IL128746A0 (en) 2000-01-31
JP2001501811A (ja) 2001-02-13
EP0931145A1 (de) 1999-07-28
EE9900092A (et) 1999-10-15
BG103238A (bg) 2000-06-30
SK34099A3 (en) 2000-05-16
PL332417A1 (en) 1999-09-13
ZA978220B (en) 1999-03-12
IS4987A (is) 1999-02-26
KR20000036058A (ko) 2000-06-26
HUP9904110A3 (en) 2001-09-28
WO1998011212A1 (de) 1998-03-19
CA2265467A1 (en) 1998-03-19
US6251853B1 (en) 2001-06-26
DE19637518A1 (de) 1998-04-09
NO991227L (no) 1999-03-12
CZ73499A3 (cs) 1999-07-14

Similar Documents

Publication Publication Date Title
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
DK0909327T3 (da) Erythromyciner og fremgangsmåder til deres fremstilling
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
EE05538B1 (et) Interleukiin-18 seostuvad valgud, nende valmistamine ja kasutamine
NO961160D0 (no) Cykliske forbindelser, deres fremstilling og anvendelse
DE69735996D1 (de) Menschlicher bikunin
NO985196D0 (no) Dispergerbare makromolekylblandinger og fremgangsmÕter for deres fremstilling og anvendelse
NO972983L (no) Sulfonamider og deres anvendelse
NO954369D0 (no) Oksazolidindionderivater, deres fremstilling og anvendelse
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NO20003067D0 (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO952575D0 (no) Flytende vanillinblanding, deres fremstilling og anvendelse
DK1141308T3 (da) Gruppe B streptococcus proteiner og deres anvendelse
DK0690065T3 (da) Biphenyl-2,2'-diyl-bis-diphenylphosphiner, deres fremstilling og deres anvendelse
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO951418D0 (no) Peptidderivater, deres fremstilling og anvendelse som terapeutika
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO912271D0 (no) Somatostatinpreparater, deres fremstilling og anvendelse.
NO991227D0 (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
NO993354L (no) Voksholdige preparater
NO972821D0 (no) 1-C-perfluoralkylglycosider, deres fremstilling og anvendelse
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application